Literature DB >> 6442099

Treatment of squamous carcinoma of the retromolar trigone.

R M Byers, B Anderson, E A Schwarz, R S Fields, R Meoz.   

Abstract

Since squamous carcinoma of the retromolar trigone is unusual, there is a paucity of information in the world's literature to use as a reference for selecting treatment and determining pertinent factors affecting prognosis. Consequently, an analysis of the medical records of 110 patients with biopsy proven squamous carcinoma originating in the retromolar trigone, seen and treated entirely at The University of Texas M.D. Anderson Hospital and Tumor Institute at Houston from 1965-1977, with at least 5 years of follow-up, was completed and constitutes the substance of this study. Local-regional control and survival were correlated with age, sex, presenting signs and symptoms, dental status, T and N classification, histologic grading, surgical findings, and the various modalities of treatment. Seventy lesions were staged T1-T2 and 77 patients had N0 necks. Thirty-five patients received a planned combination of surgery and x-ray therapy to the primary and/or neck. A composite resection was performed in 48 patients with the closure accomplished primarily or with a skin graft. The various surgical approaches are critiqued with a favorable emphasis on the marginal resection of the mandible and a modification of the radical neck dissection. The ultimate failure in the primary and the neck was 7% (8/110) and 10% (11/110) respectively. Single modality treatment whether it is surgery or irradiation appears equally adequate regardless of the T or N Stage. However, more T3-T4 cancers were treated initially with surgery. Thirty-six patients developed a second primary cancer of which 29 were in the upper aerodigestive tract. The low 5-year survival of 20% (29/110) reflects a poor salvage of the second primary and a high incidence of intercurrent disease in this elderly group of patients.

Entities:  

Mesh:

Year:  1984        PMID: 6442099     DOI: 10.1097/00000421-198412000-00011

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  5 in total

1.  Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Young-Hoon Joo; Jae-Keun Cho; Bon Seok Koo; Minsu Kwon; Seong Keun Kwon; Soon Young Kwon; Min-Su Kim; Jeong Kyu Kim; Heejin Kim; Innchul Nam; Jong-Lyel Roh; Young Min Park; Il-Seok Park; Jung Je Park; Sung-Chan Shin; Soon-Hyun Ahn; Seongjun Won; Chang Hwan Ryu; Tae Mi Yoon; Giljoon Lee; Doh Young Lee; Myung-Chul Lee; Joon Kyoo Lee; Jin Choon Lee; Jae-Yol Lim; Jae Won Chang; Jeon Yeob Jang; Man Ki Chung; Yuh-Seok Jung; Jae-Gu Cho; Yoon Seok Choi; Jeong-Seok Choi; Guk Haeng Lee; Phil-Sang Chung
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-02-02       Impact factor: 3.372

Review 2.  CT-MR integrated diagnostic imaging of the oral cavity: neoplastic disease.

Authors:  S Mazziotti; G Ascenti; E Scribano; A Mileto; S Racchiusa; C Visalli; I Salamone; S Vinci; A Blandino
Journal:  Radiol Med       Date:  2012-03-19       Impact factor: 3.469

3.  Clinicopathologic Determinants of Outcome in Pathologic T4a (pT4a) Squamous Cell Carcinoma of the Gingivobuccal Subsite of the Oral Cavity.

Authors:  Prateek V Jain; Rajeev Sharan; Kapila Manikantan; Indranil Mallick; Sanjoy Chatterjee; Indu Arun; Pattatheyil Arun
Journal:  Indian J Surg Oncol       Date:  2019-06-27

4.  Who has the opportunity to screen for oral cancer?

Authors:  J Guggenheimer; J L Weissfeld; F J Kroboth
Journal:  Cancer Causes Control       Date:  1993-01       Impact factor: 2.506

5.  Treatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities.

Authors:  Muhammad Faisal; Taskheer Abbas; Usman Khaleeq; Mohammad Adeel; Abdul Wahid Anwer; Raza Hussain; Arif Jamshed
Journal:  Cureus       Date:  2017-05-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.